2020 Artificial Intelligence Awards

Wealth & Finance International - 2020 Artificial Intelligence Awards 7 APR2w2 Much of the success of PEACCEL has come from the team’s ability to find innovative solutions to the problems facing the Life Sciences field right now. For expand, the design of proteins as drugs, diagnostics or other applications is complex, expensive, lengthy and is associated with high risks. There is no absolute guarantee of success which turns people away from investigating the possibilities. The team at PEACCEL were able to produce a cost-efficient model-based enzyme and therapeutic antibody development, thanks to the potential of AI. The analysis of the interactions between multiple drugs is too complex to be tested in a laboratory systematically, which encouraged the team to develop a system that explored the metabolic effect of millions of combinations of drugs by in silico modelling and simulation, once again with AI. The ability to turn AI to these problems has also been proven when it comes to the enzyme composition and flow of substances in bioreactors. This is crucial for good titer and yield. Using new technologies, PEACCEL has been able to model over 100 million configurations that have brought about fermentation process optimization in bioreactors. Despite these successes, and the clear potential of PEACCEL’s AI systems, it’s not easy to plan for the unforeseeable. As such, and especially in these challenging times, the team are pragmatic and optimistic about the future. PEACCEL has the ambition to become the major player in this field of AI applied to Life Sciences and does not exclude any geographical expansion. Instead, they will continue to challenge the status quo, shifting the paradigm in AI. It’s vital work, which will tackle significant unmet societal needs. Where the team hopes to thrive is in making this work open to as many people as possible. Their tools are beautifully designed, simple to use and user friendly – in short, open to as many people as possible. Only through reaching the largest possible audience, can they hope to achieve ultimate success. Currently, the team are leading the way when it comes to high value pharma / biotech products. Their solutions led to the development of drugs in a way that is faster, cheaper, with high quality with a better understanding of the biology of drugs and with a personalized / de-risked approach. It’s state-of-the-art. As the firm continues unabated by outside challenges, it’s little wonder that they expect to achieve new levels of success for years still to come. Company: PEACCEL Name of CEO: Laurent Contaut Web Address: www.peaccel.com